Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 100,000 shares at $98.91 ($9.8M) on 2025-10-01, disclosed to the SEC on 2025-10-01.
Scheduled sale ($9.8M) by EVP & Group President, Cardiology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.38 | 41,755 | $4.1M | 41.7% |
| 2 | $98.38 | 41,755 | $4.1M | 41.7% |
| 3 | $98.91 | 8,245 | $816K | 8.3% |
| 4 | $98.91 | 8,245 | $816K | 8.3% |
| Total | $98.47 avg | 100,000 | $9.8M | 100% |
| Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |
| BSX | SELL | 2025-06-04 | $11.6M | — | Filing → |